Elite Pharmaceuticals (ELTP) Stock Chart & Stock Price History $0.42 +0.00 (+0.24%) As of 04/17/2025 03:47 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Elite Pharmaceuticals Stock Price Performance 5 Day Performance+3.64%1 Month Performance-11.39%3 Month Performance-14.55%6 Month Performance-28.40%Year-To-Date Performance-22.20%1 Year Performance+215.36% Receive ELTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ELTP Stock Chart for Friday, April, 18, 2025 ELTP Chart by TradingView Elite Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$0.42$0.42$0.43$0.40349,895 shs$449.78 million04/17/2025$0.42$0.42+0.24%$0.43$0.40349,895 shs$449.78 million04/16/2025$0.43$0.42-1.27%$0.44$0.41502,955 shs$448.71 million04/15/2025$0.43$0.43+0.02%$0.45$0.42420,484 shs$454.48 million04/14/2025$0.41$0.43+4.70%$0.44$0.40360,193 shs$454.38 million04/11/2025$0.42$0.41-2.94%$0.42$0.39278,667 shs$433.97 million04/10/2025$0.41$0.42+3.08%$0.44$0.391.02 million shs$447.11 million04/09/2025$0.39$0.41+5.43%$0.41$0.371.51 million shs$433.76 million04/09/2025$0.39$0.41+5.43%$0.41$0.371.51 million shs$433.76 million04/08/2025$0.35$0.39+10.79%$0.43$0.351.78 million shs$411.43 million Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$0.35$0.39+10.79%$0.43$0.351.78 million shs$411.43 million04/07/2025$0.32$0.35+8.73%$0.37$0.272.15 million shs$371.36 million04/04/2025$0.36$0.32-11.93%$0.37$0.294.08 million shs$341.56 million04/03/2025$0.40$0.36-10.10%$0.40$0.351.77 million shs$387.82 million04/02/2025$0.44$0.40-7.17%$0.44$0.371.68 million shs$431.41 million04/01/2025$0.44$0.44$0.46$0.431.03 million shs$464.74 million03/31/2025$0.44$0.44-1.14%$0.45$0.431.32 million shs$464.74 million03/28/2025$0.47$0.44-6.38%$0.47$0.44930,205 shs$470.08 million03/27/2025$0.47$0.47-0.42%$0.48$0.46186,773 shs$502.13 million03/26/2025$0.46$0.47+1.59%$0.48$0.46463,596 shs$504.27 million03/25/2025$0.46$0.46+0.32%$0.47$0.46212,433 shs$496.36 million03/24/2025$0.46$0.46+0.94%$0.47$0.45582,958 shs$494.76 million03/21/2025$0.46$0.46+0.28%$0.47$0.45322,772 shs$490.17 million03/20/2025$0.47$0.46-2.78%$0.47$0.451.04 million shs$488.78 million03/19/2025$0.48$0.47-0.95%$0.48$0.46753,304 shs$502.77 million03/18/2025$0.49$0.48-2.04%$0.49$0.48407,701 shs$507.58 million03/17/2025$0.48$0.49+0.23%$0.49$0.47423,498 shs$518.16 million Related Companies Schrödinger Stock Price Chart NewAmsterdam Pharma Stock Price Chart Gemini Therapeutics Stock Price Chart Ascentage Pharma Group International Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart Beam Therapeutics Stock Price Chart Janux Therapeutics Stock Price Chart Kymera Therapeutics Stock Price Chart Scilex Stock Price Chart Harmony Biosciences Stock Price Chart Receive ELTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ELTP) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELTP Stock Free ELTP Stock Alerts